0001730907-19-000002.txt : 20190215
0001730907-19-000002.hdr.sgml : 20190215
20190215104150
ACCESSION NUMBER: 0001730907-19-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190215
DATE AS OF CHANGE: 20190215
EFFECTIVENESS DATE: 20190215
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclipse Therapeutics LLC
CENTRAL INDEX KEY: 0001730907
IRS NUMBER: 823570666
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-305769
FILM NUMBER: 19610212
BUSINESS ADDRESS:
STREET 1: 170 NORTH RADNOR CHESTER ROAD
STREET 2: SUITE 350
CITY: RADNOR
STATE: PA
ZIP: 19087
BUSINESS PHONE: 412-606-7214
MAIL ADDRESS:
STREET 1: 170 NORTH RADNOR CHESTER ROAD
STREET 2: SUITE 350
CITY: RADNOR
STATE: PA
ZIP: 19087
FORMER COMPANY:
FORMER CONFORMED NAME: Aclipse Therapeutics, LLC
DATE OF NAME CHANGE: 20180209
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001730907
Aclipse Therapeutics LLC
170 NORTH RADNOR CHESTER ROAD
SUITE 350
RADNOR
PA
PENNSYLVANIA
19087
412-606-7214
DELAWARE
Aclipse Therapeutics, LLC
Limited Liability Company
true
2017
Raymond
K
Houck
5 Park Place, Suite 207
Annapolis
MD
MARYLAND
21401
Executive Officer
Director
Pharmaceuticals
Decline to Disclose
- 06b
true
0001730907-18-000002
2018-01-31
true
true
true
false
0
Indefinite
1125000
Indefinite
false
4
0
0
0
false
Aclipse Therapeutics LLC
Raymond K. Houck
Raymond K. Houck
President and CEO
2019-02-15